Intraventricular Hemorrhage: Clinical Trials

2 trials for Intraventricular Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 11Unknown 1

Follow Intraventricular Hemorrhage: new trials by email Literature Review of Intraventricular Hemorrhage trials Research Report on Intraventricular Hemorrhage

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage
Tissue Plasminogen Activator, Placebo - Aneurysmal Subarachnoid Hemorrhage, Intraventricular Hemorrhage
Phase 2UnknownUniversity of Calgary122009-10-012010-11-11
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
recombinant human erythropoietin (rhEpo), Normal saline - Infant, Premature, Leukomalacia, Periventricular
Phase 1 / Phase 2UnknownChina Medical University Hospital1002009-08-012009-05-29

Narrower conditions

Leukomalacia, Periventricular (1)  ·  Premature Birth (1)  ·  Retinopathy of Prematurity (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Vascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Encephalomalacia (1)  ·  Eye Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hemorrhage (1)  ·  Infant, Newborn, Diseases (1)  ·  Infant, Premature, Diseases (1)  ·  Intracranial Hemorrhages (1)  ·  Obstetric Labor Complications (1)

Interventions

Saline Solution (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

China Medical University Hospital (1)  ·  University of Calgary (1)

Countries

Canada (1)  ·  Taiwan (1)

Top investigators

Andreas Kramer, MD (1)  ·  Bai-Horng Su, MD, PhD (1)